Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04117113 · ClinicalTrials.gov registry record
Study to Collect Information About Invasive Disease Caused by Extraintestinal Pathogenic Escherichia Coli-2 (EXPECT-2)
A clinical trial, sponsored by UMC Utrecht.
- Completed
- Registry status
- 238
- Enrollment target
NCT04117113 is a clinical trial that has completed, run by UMC Utrecht. The registered enrollment target is 238 participants.
The verdict
NCT04117113 has completed, sponsored by UMC Utrecht.
- COMPLETED
- Registry status
- 238 participants
- Enrollment target
Study Summary
The purpose of this study is to collect information from study participants who are hospitalized with an invasive disease caused by Extraintestinal pathogenic E. coli (ExPEC). This information will be used to support the development of a new vaccine to prevent Extraintestinal pathogenic Escherichia coli (ExPEC). E. coli bacteria are a leading cause of serious infections. Especially adults older than 60 years have a higher risk of developing such infections. To date, there is no vaccine available to prevent E. coli infections. To support the development of a vaccine, more information about E. coli infections is first needed. This information will be collected in the current study, such as: * Medical information such as medical history, diagnosis, duration of hospitalization * Treatment and outcome of the Extraintestinal pathogenic Escherichia coli (ExPEC) * Laboratory information
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 238 participants |
| Start Date | 2019-10-22 |
| Est. Completion | 2021-05-12 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT04117113
The ClinicalTrials.gov registry entry for NCT04117113 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 238 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is UMC Utrecht, which has 4 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 0 interventions.
NCT04117113 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT04117113 about?
NCT04117113 is a clinical study titled "Study to Collect Information About Invasive Disease Caused by Extraintestinal Pathogenic Escherichia Coli-2 (EXPECT-2)". The purpose of this study is to collect information from study participants who are hospitalized with an invasive disease caused by Extraintestinal pathogenic E. coli (ExPEC). This information will be used to support the development of a new vaccine to prevent Extraintestinal pathogenic Escherichia ...
What is the current status of trial NCT04117113?
This trial is currently completed. The enrollment target is 238 participants. The study started on 2019-10-22. Estimated completion is 2021-05-12.
Who is sponsoring clinical trial NCT04117113?
This trial is sponsored by UMC Utrecht, which has 4 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.